Last reviewed · How we verify
NCT06252805: SPOCCAT
Severe Prospective Observational COPD Catalonia
trial in Severe Chronic Obstructive Pulmonary Disease in 450 participants. Not yet recruiting.
31 March 2025
Quick facts
| Lead sponsor | Ferran Morell |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 450 |
| Start date | 10 March 2024 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2030 |
Conditions studied
- Severe Chronic Obstructive Pulmonary Disease — all drugs for Severe Chronic Obstructive Pulmonary Disease →
Sponsor
Ferran Morell
Who can join
35 and older, any sex, with Severe Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multicenter observational study to characterize and follow-up a cohort of patients with severe chronic obstructive pulmonary disease (COPD) in Catalonia
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Natural History of Severe Chronic Obstructive Pulmonary Disease: The SPOCCAT Study Protocol.
González J, Sánchez D, Ross-Monserrate D, Miguel E, et al · · 2024 · PMID 38682073 · DOI 10.1016/j.opresp.2024.100321
Verify or expand the search:
- PubMed search for NCT06252805
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ferran Morell trials
Trials by the same sponsor.
- NCT03942302 — Characterization of Variable MARrcha's Diary Variables as a Useful Measure · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06252805 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ferran Morell
- Last refreshed: 12 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06252805.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing